Apparatus and method for tissue analysis
By combining the light receiving and distribution device in the tissue analysis device, the transmission curve model is used to distinguish the type and degree of pollution, and the uncertainty caused by the light receiving window sediment under spark or plasma intervention is solved, and the biological tissue characteristics recognition is achieved. Reliability and accuracy.
Patent Information
- Application Number
- CN202111032735.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-09-03
- Filing Date
- 2021-09-03
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2041-09-03
AI Technical Summary
When intervening in biological tissue by spark or plasma, sediments are easily formed on the light receiving window, resulting in uncertainty in tissue analysis. The prior art is difficult to effectively solve this problem, especially in plasma applications accompanied by overheating. middle.
A tissue analysis device is designed, including a light receiving device and a distribution device, and the received light is evaluated through a spectrometer, the spectral composition is determined and the reliability value is assigned. The transmission curve model is used to distinguish different types and degrees of pollution, and the tissue characteristics are identified. reliability. The device can be tested when the device is not activated and dynamically adjusts the transmission curve model in practical applications to adapt to contamination changes.
Reliable identification of biological tissue characteristics is achieved, treatment errors are reduced, and tissue analysis is improved. Especially in high-contamination conditions, it can still effectively distinguish tissue types, such as healthy tissue from ulcer tissue or tumor tissue.
Smart Images

Figure CN114129253B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a device and a method for tissue analysis, in particular for integration into a surgical device. Background Art
[0002] It is known to affect biological tissue by means of an electric spark or an electrically generated plasma and to analyze the light thus generated in order to draw conclusions about the treated tissue. To this end, WO 2011 / 055369 A2 discloses a catheter for plasma ablation, wherein the catheter comprises a light receiving device in the form of an optical fiber arranged adjacent to the ablation electrode. The light received from the optical fiber is supplied to an analysis device, such as a spectrometer, and is subjected to a spectral analysis in order to be able to distinguish in particular whether the electric spark acts on a deposit, a so-called plaque, in particular the phosphorus line of the spectrum is monitored (254 nm).
[0003] The determination of the type of tissue to be treated or other tissue properties, such as non-malignant or malignant, is also known from EP 2 659 846 B1. For tissue recognition, the spark light acting on the biological tissue is analyzed based on its spectral composition. Here too, it is necessary to receive the light from the spark in the vicinity of the spark.
[0004] It is well known that during interventions on living tissue by sparks, deposits are formed on the light receiving window that affect tissue analysis. As a remedy, EP 2 815 713 B1 proposes forming the light receiving window by a stationary or flowing liquid. This will counteract the tendency of carbon black or other contaminants to deposit on the light receiving window. However, liquids do not have a geometrically defined shape, and they cannot be used in particular in plasma applications accompanied by the generation of overheating.
[0005] Due to these and other influencing factors, uncertainties depending on the specific situation may arise during the optical determination of tissue properties based on the light emitted from the spark or plasma. Summary of the invention
[0006] It is an object of the present invention to provide a concept for determining the reliability of tissue identification.
[0007] This object is achieved by a device according to claim 1 and a method according to claim 13:
[0008] The tissue analysis device according to the present invention is used for tissue identification. The spectral composition of light is evaluated for the effect of sparks on biological tissues. To this end, the tissue analysis device includes a light receiving device for receiving light generated by the effect of electric sparks or plasma on biological tissues. The light receiving device can be, for example, the end surface of an optical fiber, an objective lens attached thereto, etc. In particular, the light receiving device is preferably arranged near the electrode of the corresponding surgical instrument, and therefore close to the spark or plasma being formed. For this reason, the light receiving device may be subject to certain contamination or degradation. The contamination may be caused by the deposition of carbon black, tissue particles, dust, salt crystals or the like. The light received from the light receiving device is supplied to a spectrometer device, which determines the light intensity of at least one, preferably multiple wavelengths of light, and provides a signal to an evaluation device that characterizes the light intensity. The evaluation device determines data based on the signal characterizing the light intensity, wherein the data characterizes at least one tissue characteristic. Tissue characteristics refer to any feature that characterizes a tissue, such as tissue type (bone, blood, connective tissue, muscle, nerve, organ tissue, etc. or also different tumor tissues). The tissue characteristics to be distinguished may also be characteristics within a tissue type, for example, whether it is healthy tissue or ulcer tissue, tumor tissue, infected tissue, dead tissue, etc.
[0009] The assigning device is part of the tissue analysis device and is used to assign reliability values to data determined by the evaluation device. The assigning device is configured to determine the reliability value based on the contamination of the light receiving device. The determination of the contamination is performed indirectly because the spectrum to be evaluated is generated by the spectrometer device. The spectrum can be derived from a light source of known spectral composition, or it can also be derived from light that emits sparks acting on the tissue. If the light source is from a light source of known spectral composition, the evaluation is particularly simple. From the spectrum provided by the spectrometer device, the type and degree of contamination can be directly derived, and the contamination can therefore be classified. Different contamination categories can correspond to different transmission curves, which affect the light emitted by the light source and received by the light receiving device like a filter curve. Reliability values for different tissue characteristics (such as different tissue types) can be assigned to different transmission curves. For example, also in the case of severe contamination, some tissue types can still be identified in a fairly reliable manner, while other tissue types cannot be identified in a fairly reliable manner, even in the case of low contamination.
[0010] However, in such a scheme of contamination determination, the test device must be used from time to time in order to provide light of known spectral composition to the light receiving device. The light source may be part of the test device, which is arranged so that the light emitted therefrom is detected by the light receiving device. For example, if there is no spark on the electrode of the corresponding instrument, the light source may be a light source that is always emitting light. If there is a spark, it may be turned off (not emitting light).
[0011] As an alternative, the test device can use a surgical field lighting as a light source. This applies in particular if the surgical field lighting emits light in a wavelength range relevant for tissue identification. Furthermore, it is advantageous if the brightness of the surgical field lighting is sufficiently constant. The test can be performed if the instrument has not yet been activated and as an option, always if the instrument has not yet been activated.
[0012] In another embodiment, such a light source is omitted or the surgical field illumination is not used for test purposes. Instead, the light emitted from the spark and received by the light receiving device is supplied to the spectrometer device, which determines the assigned spectrum. In this case, the assigning device can be connected to a data block containing a plurality of transmission curve models, which are characteristic of different contaminations. The transmission curve models are in turn filter curves, which can be distinguished for their qualitative shape and their wavelength-dependent attenuation values. In this case, the assigning device is configured to identify the transmission curve model that matches the recorded spectrum.
[0013] In both embodiments, the data set is assigned to a transmission curve model that assigns different reliability values to different tissue properties. These data are used to further evaluate the spectrum. For example, if the manufacturer or user is defining a reliability value of at least 98%, and if the effective transmission curve model in this example includes a reliability above this limit only for some of the tissue properties that can be determined in principle, the allocation device can be configured to indicate only those tissue types that are provided with sufficient reliability. As an alternative, the relevant reliability value of each determined tissue property can be indicated. In order to avoid treatment errors, low reliability can be signaled optically or acoustically. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Further details of advantageous embodiments of the invention are obtained from the dependent claims, the drawings or the corresponding description. The drawings show:
[0015] Figure 1 is a schematic block diagram illustrating an organization analysis device,
[0016] Figure 2 It is part of a tissue analysis device used to illustrate the basic operating principles.
[0017] Figure 3 is the transmission curve model of different contaminations of the light receiving device,
[0018] Figure 4 is a spatial illustration of the reliability values depending on the type and magnitude of pollution,
[0019] Figure 5 are the different reliability curves for different tissue characteristics with increasing contamination,
[0020] Figure 6 is a block diagram of a tissue analysis device having a test device. DETAILED DESCRIPTION
[0021] Figure 1 A tissue analysis device 10 is shown, which is configured to identify specific tissue properties G based on light generated by sparks 12 affecting biological tissue 11. The sparks 12 may originate from an electrode 13 of a surgical instrument 14, which is supplied with power by a device 15. For example, the electrode 13 is supplied with a radiofrequency current in such a way that the radiofrequency current flows through the tissue 11 and the corresponding counter-electrode. For example, the instrument 14 is a monopolar instrument, which requires a neutral electrode in order to close the circuit, which must be attached to the patient (while Figure 1 The tissue analysis device 10 can also cooperate with a bipolar instrument comprising two or more electrodes between which a spark is ignited. As soon as the spark 12 or the plasma jet generated thereby touches the tissue 11, a light appearance is produced, the spectrum of which allows conclusions to be drawn about the type and condition, i.e., the properties, of the tissue 11.
[0022] The tissue analysis device 10 may be part of the instrument 14 or may be configured as a separate unit for determining such tissue properties G. The tissue analysis device 10 is configured to determine and indicate relevant properties of the tissue, such as what type of tissue (e.g., connective tissue or organ tissue) is in contact with the spark.
[0023] The light receiving device 16 is part of the tissue analysis device 10 and is in the form of a light conductor 17, for example, whose distal end 18 forms a light receiving window and is arranged near the electrode 13 and / or the spark 12. The light receiving window can also be formed by a lens, an objective lens or the like.
[0024] The light receiving device 16 is connected to the spectrometer device 20 and provides the received light generated by the spark 12 to the spectrometer device 20. The spectrometer device 20 is configured to determine the spectrum of the light. The spectrum is characterized by the light intensity presented by light of different wavelengths. Any kind of spectrometer can be suitable as the spectrometer device 20, which can be suitable for outputting signals representing different light intensities at different light wavelengths on the conductor 21.
[0025] The conductor 21 connects the spectrometer device 20 with the evaluation device 22, which is configured to determine the tissue characteristic G from the spectrum measured by the spectrometer device 20 (i.e., from the signal output by it). The tissue characteristic G to be determined can be a tissue type or a specific feature of a tissue type. For example, specific features (ion content, phosphorus content or other subtle features) of the tissue type (muscle tissue, bone tissue, adipose tissue, blood, etc.) can be examined. To this end, the evaluation device can be trained based on many different tissue samples and can include corresponding learning algorithms or other learning structures. To this end, the evaluation device 22 can also use a clearly defined calculation algorithm or other evaluation algorithm. The evaluation device 22 generates data D that characterizes the tissue characteristics. For example, the data D can be suitable for indicating the tissue type to distinguish between malignant tissue and non-malignant tissue, etc.
[0026] The tissue analysis device 10 further comprises an assignment device 23, which is configured to assign a reliability value R to the data D. The data D and the reliability value R can be provided to the display device 25 via the conductor 24. The reliability value is determined based on the transmission measurement value and is applicable to all subsequent data D until the next transmission measurement. Thus, the reliability of the tissue classification and the potential reduction of the reliability are assigned to the measurement value quasi-in advance.
[0027] The evaluation device 22, the distribution device 23 connected thereto and their cooperation are Figure 2 The allocation device 23 is particularly used to determine the degree of reliability with which a specific tissue characteristic G can be determined. In general, the reliability decreases as the contamination of the light receiving device 16 increases. However, this does not apply equally to all tissue characteristics G to be determined. For example, in the case where the light receiving device or its light receiving window has been significantly contaminated, fat tissue can still be well distinguished from bone tissue; while in the case of lower contamination levels, for example, more subtle distinctions between similar tissue types or distinctions between non-malignant and malignant tissues may have become unreliable.
[0028] The contamination of the light receiving window changes its transmission characteristics. The deposits on the light receiving window have an effect similar to that of a filter and thus have a spectrum distortion effect. The distribution device can provide various transmission curve models 26, which have characteristics for different contaminants V (V1, V2...Vn). For example, the transmission curve of the pollution-free V1 has an all-pass characteristic, while the transmission curves V2...Vn are transmission curves with low-pass or band-pass characteristics, or transmission curves of filter curves with multiple minimum values, maximum values and / or inflection points. For this purpose, Figure 3 A typical change in the transmission curve is shown during an increase in contamination from 1 to 8. The curve shows the light intensity I as a function of the light wavelength λ.
[0029] During the identification of the tissue properties G, for each transmission curve model 26 with different contaminations V1 to Vn, a different reliability value R is obtained. Figure 5 The different tissue types from type A to type F are described in . Figure 3 , the contamination is numbered from 1 to 8, which corresponds to an increase in the degree of contamination. At a contamination degree of 1 in almost all tissue types except types C and E, a reliability close to 100% is still obtained. As the degree of contamination increases (2, 3, 4, etc.), the reliability decreases according to the tissue type, with different decreases. This applies to tissue types A to F and other tissue properties G or tissue features. At a defined contamination degree, for example 3, some tissue properties G, such as properties of type B, can still be reliably determined, type D is reliable to some extent, while, for example, other types or properties are no longer reliable. This information, i.e. which tissue properties G can be determined with which reliability, is part of each transmission curve model 26 of V1 to Vn.
[0030] The evaluation device 22 first determines the desired tissue characteristic G, such as the tissue type. The allocation device 23 then allocates the corresponding reliability value R to the characteristic based on the corresponding effective transmission curve model 26 (V1, V2 ... or Vn). Both data can be provided to the display device 25 via the conductor 24 and displayed there. Therefore, the data D characterizes, for example, the identified tissue type or another tissue characteristic G. The reliability value R thus characterizes the reliability that the determined tissue characteristic G has.
[0031] In at least one embodiment of the invention, the determination of the reliability value R can be performed before the actual application. In this way, the reliability value R can also be subsequently assigned to the transmittance measured during operation. For example, before a fiber with 100% transmittance is applied to the test tissue, the spectrum can be recorded and the tissue can be classified. Subsequently, different transmission curve models can be used to simulate different contaminations. Using these transmission curve models, the tissue can then be classified again. By comparing with the tissue classified with 100% transmittance, it can be determined to what extent which transmission curve model deteriorates the reliability of the tissue analysis.
[0032] This can then be used during an application to decide whether a fiber with a certain transmittance measured during the application is still good enough for the current tissue classification.
[0033] The indication of the tissue properties G (data D) may also be prevented if the reliability value R falls below a defined or selected limit.
[0034] The transmission curve model 26 may be a one-dimensional model that only characterizes the increase in contamination, such as Figure 3 and Figure 5However, it is also possible to configure a classification of different pollutions, so that a distinction can be made between pollution types T and pollution magnitudes or degrees K. For example, the pollution type may depend on the type of pollution (carbon black deposits, tissue deposits, other smoke deposits). This may be the case in particular if the corresponding particle sizes are different. The pollution degree K can then characterize the thickness of the deposits formed. For example, the pollution type T can define different filter curves, such as low-pass or band-pass or a combination of different basic characteristics, while the pollution degree characterizes the cut-off frequency, the slope or other parameters of the filter curve.
[0035] The allocation device 23 must select from the provided transmission curve models 26 the model that best matches the respective contamination. Figure 2 For the first spectrum 27, in the case of an uncontaminated light receiving device 16 on a specific tissue type (e.g. muscle tissue), the spectrum will be symbolized as a recorded spectrum. There are a number of spectral lines A, B, C that appear with different intensities I. The number of spectral lines and their intensities depends on the corresponding tissue type. They are only Figure 2 . If now, due to the contamination of the light receiving device 16, a different spectrum 28 is recorded on the corresponding tissue, such as muscle tissue, its spectrum is modified due to the contamination. Although the spectrum 27 shows the spectrum lines A, B, C, the spectrum 28 includes the spectrum lines A, B, C, that is, one or more spectrum lines have an intensity I lower than the intensity of the clean light receiving device 16. However, if the surgeon knows which tissue the spectrum is generated from, and if this information is available to the evaluation device 22, the surgeon can determine which transmission curve model 26 must have affected the modification of the spectrum based on the modification of the spectrum 28 compared with the ideal spectrum 27, and can select the corresponding transmission curve model from the group of available models V1 to Vn. When selecting the transmission curve model, the evaluation device 22 simultaneously obtains an evaluation of the reliability from the allocation device 23, which can be used to identify specific tissue characteristics. Since the reliability values R of the transmission curve model for all other tissue properties G are known, the surgeon can work continuously with his / her instruments and can affect different tissue types, while the display device 25 always indicates to him / her the determined tissue property G (e.g. tissue type) and the assigned reliability value R, with which the tissue property G (e.g. tissue type) has been identified.
[0036] The selection of the corresponding transmission curve model can be checked after predetermined time intervals, for example after one or more seconds respectively. The transmission model can also be extrapolated based on the activation time and the contamination rate to date. The extrapolation can be checked with the transmission measurement values at defined time intervals or at given opportunities, for example between instrument activations. The surgeon does not need to perform a separate calibration.
[0037] In a modification of the present invention, a testing device 30 may also be provided, such as Figure 6 . It comprises a light source 31, with which light having a defined spectral composition can be supplied to the light receiving window of the light receiving device 16. The control device 34 thus coordinates the test process, since it activates the light source 31 from time to time so that the light enters the light receiving window of the light receiving device 16. The spectrometer 20 outputs its data under this test condition via a switch 32 to a transmission classifier 33, which determines the degree of contamination K and / or the type of contamination T. The start of the test and the control of its progress are controlled by the control device 34, which can be part of the test device 30.
[0038] Alternatively, surgical field lighting can be used as light source 31. For this purpose, short operating interruptions can be used, during which the electrode 13 does not emit sparks 12. The control device 34 can use these operating interruptions accordingly and process the routine for determining a suitable transmission curve model.
[0039] The contamination degree K and / or contamination type T provided by the transmission classifier 33 is supplied to the allocation device 23, which then selects the reference Figure 2 A matching transmission curve model 26 similar to that described previously is provided. The transmission measurement value provides information about the degree of contamination. The transmission classifier 33 and / or the allocation device 23 can be configured to determine comparable transmission curve models (selected from a library) and determine which tissue classifications have which reliability R is possible. Therefore, the transmission classifier 33 and / or the allocation device 23 can be configured to perform interpolation between comparable transmission curve models based on the degree of contamination and / or the type of contamination.
[0040] If the test is terminated, the control device 34 switches the switch 32 again so that the signal supplied by the spectrometer 20 is directed to the evaluation device 22, which now again determines the expected tissue properties from the spectrum obtained from the spark light. These tissue properties are provided in the form of data to the display device 25, which indicates the tissue properties.
[0041] In this way, the transmission classifier 33 and the distribution device 23 can predict how good the result of the tissue classification is based on the measured transmittance. For example, by using the actual fibers that are contaminated, the tissue classification provides 92% correct results. In the case of clean fibers, the tissue classifier provides, for example, 96% correct results. With the help of the transmission classifier 33, the measured transmittance can now be subdivided into transmittances that reach, for example, 92% and better, and transmittances for which the expected quality of the tissue classification is less than 92%.
[0042] The data D are supplied to a tissue classifier 33 for tissue determination of the tissue type. The tissue type and the determined reliability value R are now supplied to the display device 25. It can display the reliability value R. The display device can also emit a signal if the reliability value is below a threshold value. The threshold value can be fixed or defined in a variable manner.
[0043] The tissue analysis device 10 according to the invention has a light receiving device 16 and a spectrometer device 20 for determining a tissue characteristic G, and for this purpose comprises an evaluation device 22 connected to an assignment device 23. The evaluation device 22 is used to determine at least one tissue characteristic G of a biological tissue, such as its type or disease infection. The assignment device is used to assign a suitable transmission curve model 26, which models the contamination of the light receiving device 16. For different degrees of contamination, different transmission curve models are provided, which include a reliability value R for each tissue characteristic G that can be determined separately. With the concept of the invention, not only can tissue analysis be achieved, but also an indication of the reliability of the analysis, that is, how reliable the indication of the tissue characteristic G is.
[0044] Reference Symbols List:
[0045] 10. Tissue analysis device
[0046] 11 Biological tissue
[0047] 12 Spark
[0048] 13 Electrodes
[0049] 14 Instruments
[0050] 15 Equipment
[0051] 16. Light receiving device
[0052] 17 Photoconductor
[0053] 18 Distal end of the optical fiber 17
[0054] 20 Spectrometer Device
[0055] 21 Conductor
[0056] 22 Evaluation Device
[0057] G. Tissue Characteristics
[0058] D Data
[0059] 23 Distribution device
[0060] 24 Conductor
[0061] 25 Display device
[0062] 26 Transmission Curve Model
[0063] V, V1 … Vn Contamination / transmission curve
[0064] I Light intensity
[0065] λ Light wavelength
[0066] T Pollution Type
[0067] K Pollution degree
[0068] R reliability value
[0069] 27 First Spectrum
[0070] 28 different spectra
[0071] 30 Test equipment
[0072] 31 Light Source
[0073] 32 Switch
[0074] 33 Transmission Classifier
[0075] 34 Control Devices
[0076] 35 Fiber optic connector.
Claims
1. A tissue analysis device (10) for integration into a surgical instrument (14) and / or a device (15) for supplying said instrument, having a light receiving device (16) for receiving light generated by the impact of an electric spark (12) or plasma on a tissue (11), A spectrometer device (20) is provided for determining the light intensity of light of different wavelengths, An evaluation device (22) is provided for determining data (D) characterizing at least one tissue property (G) from the light intensity, An assignment device (23) is provided for assigning and / or determining a reference or reliability value (R) for a tissue property (G) based on the contamination (V) determined by the light receiving device (16).
2. The tissue analysis device according to claim 1, It is characterized in that The assigning device (23) is configured to perform a classification of the contamination (V) based on the light intensity determined by the spectrometer device.
3. The tissue analysis device according to claim 1, It is characterized in that A testing device (30) is provided, the testing device (30) being configured to classify contamination.
4. The tissue analysis device according to claim 2, It is characterized in that The classification comprises assigning the pollution (V) to one or more pollution types (T).
5. The tissue analysis device according to claim 3, It is characterized in that The testing device (30) is configured to detect the degree (K) of the contamination (V).
6. The tissue analysis device according to claim 5, It is characterized in that The assigning device (23) is configured to determine the reliability value (R) based on the contamination (V), wherein the reliability value (R) is specific to the tissue property (G) to be determined by the evaluation device (22).
7. The tissue analysis device according to any one of claims 1 to 6, It is characterized in that The allocation means (23) comprises a model regarding the relationship between the reliability value (R) with which the specific tissue property (G) is identified and the contamination (V).
8. The tissue analysis device according to claim 7, It is characterized in that The model is a collection of data.
9. The tissue analysis device according to any one of claims 1 to 6, It is characterized in that The distribution device (23) comprises a plurality of transmission curve models (26) having characteristics for different contaminations (V).
10. The tissue analysis device according to claim 9, It is characterized in that The assigning device (23) selects a matching transmission curve model (26) based on a spectrum (28) obtained by the spectrometer device (20).
11. The tissue analysis device according to claim 9, It is characterized in that A reliability value (R) is assigned to each transmission curve model (26) for each tissue characteristic (G).
12. The tissue analysis device according to any one of claims 1 to 6, It is characterized in that A test device (30) for determining contamination (V) is provided, the test device comprising a light source (31) emitting multi-spectral light.
13. The tissue analysis device according to claim 12, It is characterized in that The testing device (30) is configured to determine the contamination (V) based on a plurality of light wavelengths.
